Early surgical management of invasive gingival aspergillosis in a neutropenic patient with leukemia: a case report.
Primary invasive aspergillosis of the oral cavity is a rare but serious complication in immunocompromised patients. We report a case of gingival Aspergillus infection in a neutropenic patient with acute myelogenous leukemia, who was successfully treated by an early surgical approach in combination with antifungal medication and granulocyte colon stimulating factors.
Myoken
Y
Y
Department of Dentistry, Hiroshima Red Cross-Atomic Bomb Survivors Hospital, Japan.
Sugata
T
T
Kyo
T
T
Fujihara
M
M
Mikami
Y
Y
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000601:surgery*; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D005882:Gingival Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D009503:Neutropenia / Q000150:complications*
D000935:Antifungal Agents; D016179:Granulocyte Colony-Stimulating Factor; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine